Charles River Laboratories (CRL)

Charles River Laboratories (CRL) is a Diagnostics & Research company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $16.6B; returns 1 day +1.7%, 1 week +15.1%, 1 year +80.9%.

Charles River Laboratories International, Inc. (CRL) is a global contract research organization (CRO) providing essential products and services to help pharmaceutical, biotechnology, and medical device companies develop and bring new therapies to market. CRL operates in three core segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions.

Groups CRL belongs to

• Healthcare
• Shrinking Share Count
• Life Sciences
• S&P 500
• Life Sciences Tools & Services
• Contract Development and Manufacturing Organizations (CDMO)
• Biotechnology
• Pharmaceuticals
• Biopharmaceutical
• Outsourcing
• Preclinical Development
• Drug Discovery
• R&D
• Biologics
• Contract Manufacturing
• Healthcare Services

CRL financial model: income statement, cash flow and balance sheet